Skip to content
About
Our Mission
The challenge
Deliberables
Structure
Core Group
Management Committee
Working Groups
WG1: Tools for NRF2 research
WG2: Pharmacological regulation and drugs
WG3: Translational medicine
WG4. Economic Exploitation
WG5: Outreach and dissemination
Events
Scientific Meetings
Webinars
Training Schools
Open Days
Podcasts
News
Newsletters
Special Issues
Other news
Projects
Dissemination
Co-authored Action publications
Collaborative publications
Open Days
About
Our Mission
The challenge
Deliberables
Structure
Core Group
Management Committee
Working Groups
WG1: Tools for NRF2 research
WG2: Pharmacological regulation and drugs
WG3: Translational medicine
WG4. Economic Exploitation
WG5: Outreach and dissemination
Events
Scientific Meetings
Webinars
Training Schools
Open Days
Podcasts
News
Newsletters
Special Issues
Other news
Projects
Dissemination
Co-authored Action publications
Collaborative publications
Open Days
Intranet
Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets
01/04/2023
Bourgonje AR, Grochot-Przęczek A, Feelisch M, Cuadrado A, van Goor H.
By:Bourgonje AR, Grochot-Przęczek A, Feelisch M, Cuadrado A, van Goor H.
Go to publication
